Imugene Ltd Sustainability Reports
Imugene Limited is a clinical-stage immuno-oncology company developing novel cancer therapies. Its platform technologies seek to activate the body's immune system to identify and eradicate tumors.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 984500A5C9KF08EAF248
FIGI: BBG001S7H440
12 reports from 2007 to 2026
